Pfizer launches phase 3 trial of coronavirus vaccine with 30K participants | The Hill: Healthcare Policy

Drugmaker Pfizer on Monday became the second drugmaker to announce it had begun phase 3 testing of a vaccine to prevent the spread of coronavirus.CNBC reported that the company, along with German biotech company BioNTech, announced the beginning of...